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Abstract Matrix metalloproteinases (MMPs) are a family of
endopeptidases that degrade extracellular matrix components.
Membrane-type 5 MMP (MT5-MMP/MMP-24) was identi¢ed
as neuron-speci¢c, and is believed to contribute to neuronal
circuit formation and plasticity. To elucidate its function in
vivo, we have generated mice lacking MT5-MMP by gene tar-
geting. MT5-MMP-de¢cient mice were born without obvious
morphological abnormalities. No apparent histological defects
were observed in the nervous system either. However, MT5-
MMP-de¢cient mice did not develop neuropathic pain with me-
chanical allodynia after sciatic nerve injury, though responses to
acute noxious stimuli were normal. Neuropathic pain induced by
peripheral nerve lesions is known to accompany structural reor-
ganization of the nervous system. Intraneural injection of chol-
era toxin B subunit, a transganglionic tracer, into the injured
sciatic nerve of wild-type mice revealed that the myelinated AL-
¢ber primary a¡erents sprouted from laminae III^VI of the
dorsal horn of the spinal cord and invaded lamina II. However,
no such sprouting and invasion of AL-¢bers were observed in
MT5-MMP-de¢cient mice. These ¢ndings suggest that MT5-
MMP is essential for the development of mechanical allodynia
and plays an important role in neuronal plasticity in this mouse
model.
/ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Pericellular proteolysis is an important step in the regula-
tion of various cellular functions in tissue through proteolytic
conversion of the proteins in the extracellular milieu [1,2].
Matrix metalloproteinases (MMPs) are a family of zinc-de-
pendent endopeptidases that are responsible for degradation
and processing of protein components in the extracellular ma-
trix (ECM) and cell surface molecules including cell adhesion
molecules, cytokines, growth factors, and receptors [3,4]. Be-
cause of this activity, MMPs have been implicated not only in
a wide array of physiological processes [5], but also in diverse
pathological states [3,6]. Although most MMPs are secreted
enzymes, six are membrane-type MMPs (MT-MMPs) having
either a type I transmembrane domain (MT1-, MT2-, MT3-
and MT5-MMP) or a glycosylphosphatidylinositol-anchor
(MT4- and MT6-MMP) [7]. These MT-MMPs are particu-
larly suitable for the pericellular proteolysis that regulates
cellular functions.
MT5-MMP (MMP-24) was identi¢ed as a brain-speci¢c
MMP [8,9] and its expression was speci¢cally detected in neu-
rons of both the central and peripheral nervous systems
[10,11]. During embryonic and early postnatal development
in rodents, MT5-MMP is abundantly expressed throughout
the nervous system [10,12]. Subsequently in adults, signi¢cant
expression levels are maintained in regions of neuronal plas-
ticity, such as the cerebellum and hippocampus [10^12]. The
temporal and spatial regulation of the expression suggests that
MT5-MMP plays roles in neuronal circuit formation and
plasticity. To gain further information on the roles of MT5-
MMP in vivo, we generated MT5-MMP-de¢cient mice by
targeted disruption of the gene (mmp-24).
2. Materials and methods
2.1. Generation of MT5-MMP-de¢cient mice
Genomic DNA fragments were obtained by screening a mouse 129/
SvJ genomic library in lambda FIX II (Stratagene). A targeted con-
struct was designed to replace the 3.3-kb genomic fragment of mmp-24
containing exon 5 and part of exon 6 with a MC1-neo cassette (neo).
The 5P 4.3-kb (XbaI^HindIII fragment) and 3P 5.5-kb (BamHI^ClaI
fragment) fragments were used as sites of homologous recombination
between the vector and the genomic sequences (Fig. 1). The diphtheria
toxin A gene regulated by the MC1 promoter (DT-A) was added to
the 3P end. The targeting vector was linearized at the XbaI site and
introduced into the embryonic stem (ES) cell line E14-1 by electro-
poration. The cells were selected in medium containing G418 (400 Wg
ml31 ; Invitrogen) and drug-resistant clones were tested for homolo-
gous recombination by Southern blot analysis with speci¢c probes.
Three clones containing the mutated mmp-24 allele were identi¢ed
and Southern blot analysis was performed further with the neo probe
to con¢rm the single targeting event. Cells from two independent
targeted clones were microinjected into C57BL/6J blastocysts and chi-
meric male founders were obtained. To obtain MT5-MMP-de¢cient
mice on an inbred congenic genetic background, the heterozygous
mice obtained were backcrossed to strain C57BL/6J for at least eight
generations. These heterozygous mice were then intercrossed to gen-
erate homozygous mice.
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2.2. Neuropathic pain model
To generate a neuropathic pain that mimics mechanical allodynia in
mice, the sciatic nerve was injured by ligation or transection as de-
scribed in previous studies [13,14] and the response to a mechanical
stimulus was measured. Mice used for the experiment were prepared
by crossing the heterozygous mice, but the observer was blind to the
genotype throughout the experiment. Twelve-week-old mice were
anesthetized with sodium pentobarbital (50 mg kg31, i.p.). The right
sciatic nerve was exposed at mid-thigh level and tightly ligated with
8^0 silk suture around approximately 1/3 to 1/2 the diameter of the
nerve or transected. As a control, the left sciatic nerve was subjected
to a sham operation with the same surgical procedure without nerve
injury. Before the test to measure the response to the mechanical
stimuli, mice were placed in a transparent plastic box with a metal
mesh £oor and allowed to acclimate for 15 min. The mid-planter
surface of the hind paw was stimulated using von Frey ¢laments
(North Coast Medical, Inc.) for 6^8 s with increasing force. The force
of stimuli that cause a brisk withdrawal in 50% of the trials was
calculated by using the up^down method of Dixon, as described pre-
viously [15], and presented as the 50% withdrawal threshold. The
values were expressed as the meanNS.E.M. Mechanical allodynia
can be observed as a decrease in the threshold to the stimuli. All
the experiments were performed in accordance with the guidelines
presented by the Ethics Committee of the International Association
for the Study of Pain [16].
2.3. Speci¢c labeling of AL-¢bers using cholera toxin B subunit (CTB)
conjugated with horseradish peroxidase (CTB-HRP)
Two weeks after the surgical operation, mice were anesthetized and
the sciatic nerves on both sides were re-exposed. Two Wl of a 1.5%
solution of CTB-HRP was injected into the proximal site of the in-
jured sciatic nerve using a 33G needle and Hamilton microsyringe.
Three days after the CTB-HRP injection, the animals were anesthe-
tized and the fourth and ¢fth lumbar (L4 and L5) segments were
dissected out. Following a rinse with normal saline, the specimens
were immersed and ¢xed with 4% paraformaldehyde in 0.1 M phos-
phate bu¡er (pH 7.4) for 1 h at 4‡C and stored overnight in 30%
sucrose in 0.1 M phosphate bu¡er at 4‡C. Fifty-Wm-thick transverse
sections of spinal cord were cut and were processed for HRP histo-
chemistry using tetramethylbenzidine as the chromogen [17].
3. Results and discussion
3.1. Generation of MT5-MMP-de¢cient mice
To disrupt the mmp-24 gene in mice, the 3.3-kb genomic
fragment containing exon 5 and part of exon 6 was substi-
tuted with a segment containing a drug-resistant neo gene
(MC1-neo cassette) in ES cells (Fig. 1A). The deletion results
in a loss of the zinc-binding site in the catalytic domain, which
is essential for the enzyme activity, and a frame shift at the
junction between exons 4 and 7 in the ¢nal mRNA product.
Thus, the mutated gene encodes only a propeptide sequence
with the residual N-terminal part of the catalytic fragment.
Heterozygous mice having the mutated mmp-24 allele were
obtained with no obvious defects and were interbred to gen-
erate homozygous mice. To determine the genotypes of the
progeny, genomic DNA was obtained and analyzed by South-
ern blotting using the 5P probe and 3P probes after digestion
with SspI or SacI (Fig. 1B). To examine the expression of the
mutated gene, Northern blot analysis of total RNA derived
from neonatal whole brain was performed (Fig. 1C). A 4.5-kb
mRNA band was detected in the wild-type and the heterozy-
gous mice, but it was absent in the homozygous mice. A faint
band at 4.1 kb that is presumably derived from the mutated
gene appeared in the heterozygous and homozygous mice.
MT5-MMP-de¢cient mice were born in the predicted Men-
delian ratio (29.7% wild-type, 44.8% heterozygous, and 25.3%
homozygous, n=205) following intercrosses between hetero-
zygous mice. The null mice have a normal appearance, fertil-
ity, and lifespan. General behavioral analysis demonstrated no
signi¢cant di¡erence between the wild-type and null mice ex-
cept for the following. In the rotarod test to assess motor
abilities, mice were placed on the rotating drum individually
and the number of falls in a 3-min period was counted. MT5-
MMP-de¢cient mice exhibited signi¢cantly less falls than the
wild-type mice (7N 0.7 versus 2 N 0.3 (5 week old) and 2N 0.4
versus 0.2 N 0.1 (8 week old), P6 0.01, Student’s t-test). In the
water T-maze test to evaluate learning ability, the null mice
did not try to swim by just £oating on the water. However,
they started to swim like wild-type mice when they were
picked by an observer. Thus, MT5-MMP de¢cient mice may
have defect to feel the stress in water. Histologic examination
of sections from the nervous tissues including brain, spinal
cord and dorsal root ganglion did not demonstrate obvious
abnormalities in the null mice (data not shown).
3.2. Absence of mechanical allodynia after sciatic nerve injury
in MT5-MMP-de¢cient mice
MT5-MMP-de¢cient mice did not show any obvious defects
under physiological conditions. Then, we examined the e¡ect
of the MT5-MMP de¢ciency on the development of a severe,
long-lasting neuropathic pain caused by lesions in the nervous
system [18]. One characteristic feature of neuropathic pain is
mechanical allodynia, which is de¢ned as pain evoked by non-
noxious mechanical stimuli. Clinically, no adequate therapies
are available for neuropathic pain and, therefore, several ex-
perimental animal models have been developed to study the
mechanisms involved [13,14,19,20]. Peripheral nerve injury in
animals is known to cause this type of chronic pain even after
complete healing of the injured tissues and also induces struc-
tural reorganization of the terminal nerve ¢bers in the dorsal
horn spinal cord based on the plasticity of the injured neurons
[21^23].
To examine the potential involvement of MT5-MMP in the
Fig. 1. Gene targeting of MT5-MMP in the mouse. A: Targeting
strategy. The relative positions of exons 5^9 (solid boxes) are indi-
cated. The targeting vector contains a MC1-neo cassette (neo)
£anked by loxP (arrowheads) and a diphtheria toxin A gene driven
by the MC1 promoter (DT-A). Arrows indicate the transcriptional
direction. The positions of the external 5P and 3P probe used for de-
lineation of the target event are illustrated. B: Southern blot analy-
sis of mouse tail DNA isolated from the progeny of a mating be-
tween heterozygous parents. C: Northern blot analysis of total
RNA from whole brains of neonatal mice.
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mouse neuropathic pain model, the sciatic nerve on the right
side was partially ligated and paw withdrawal in response to
mechanical stimuli added to the mid-planter surface of the
hind paw was monitored. The force of stimuli that caused a
withdrawal response in 50% of trials (50% threshold) is indi-
cated in Fig. 2. Withdrawal response in the sham-operated left
side was measured as a control. In the wild-type mice, the
threshold of the response to the stimuli decreased signi¢cantly
and persisted for at least 28 days (Fig. 2A). Basically the same
result was obtained when the sciatic nerve was injured by
transection (data not shown). In contrast, MT5-MMP-de¢-
cient mice did not show a decrease in the threshold value of
the response to mechanical stimuli (Fig. 2B). Thus, MT5-
MMP looks indispensable to the occurrence of mechanical
allodynia after peripheral nerve injury.
However, there is a possibility that the absence of neuro-
pathic pain in the MT5-MMP-de¢cient mice is a result of
reduced transmission of pain sensation. We think this is not
the case, because no di¡erence was observed in the paw with-
drawal responses between wild-type and MT5-MMP-de¢cient
mice on the sham-operated side. In addition, responses of
MT5-MMP-de¢cient mice to various noxious stimuli, such
as heat, formalin, and acetic acid, appeared normal compared
to the wild-type mice (data not shown).
3.3. Transganglionic labeling of the central terminals of
primary a¡erents in the dorsal horn of the spinal cord
Previous studies have demonstrated that peripheral nerve
lesions induce neuronal plasticity with structural reorganiza-
tion [21^23]. The central termination pattern of primary a¡er-
ents has been found to change profoundly in the dorsal horn
of the spinal cord following peripheral nerve damage in rat.
Myelinated AL-¢bers, which only elicit innocuous sensations,
terminate in laminae III^VI in the dorsal horn (Fig. 3). Within
2 weeks after peripheral nerve injury, AL-¢bers sprout from
laminae III^VI and invade lamina II where unmyelinated C
¢bers terminate and nociceptive-speci¢c neurons are dominant
(Fig. 3). This structural reorganization is believed to be im-
portant for the sustained neuropathic pain. In addition, the
AL-¢bers form synapse-like structures in lamina II [23^25]
and novel mono- or polysynaptic AL ¢ber-mediated inputs
can be detected there [26^28]. These results suggest that the
extended AL-¢bers transmit an innocuous coetaneous sensa-
tion to neurons of the super¢cial dorsal horn that normally
receive a nociceptive input. Thus, the observed structural re-
organization is considered to be important for the sustained
neuropathic pain with mechanical allodynia.
MT5-MMP is expressed in isolated dorsal root ganglion
neurons [10] that express a myelinated A-¢ber marker, 200-
kDa neuro¢laments (NF200) [29]. In addition, MT5-MMP
was particularly localized to the growth cone, the leading
structure of growing axons. Thus, MT5-MMP-de¢cient mice
may be defective in the sprouting and invasion by AL-¢bers in
the dorsal horn. To examine this possibility, we used CTB
which binds to the GM1 ganglioside present on myelinated
A-¢bers but not on unmyelinated C-¢bers as a retrograde and
transganglionic tracer [29]. CTB-HRP was injected into the
proximal site of the damaged sciatic nerve and its transport
to the dorsal horn of the spinal cord was monitored (Fig. 3).
When CTB-HRP was injected into the sham-operated sites
of both wild-type and MT5-MMP-de¢cient mice, speci¢c la-
beling of laminae III^VI in the spinal dorsal horn was ob-
served and lamina II was not stained at all (Fig. 4A,C). This
staining pattern is consistent with previous studies [22,25,30].
When CTB-HRP was injected into the injured side of wild-
type mice, extended labeling of lamina II was observed (Fig.
Fig. 2. Assessment of mechanical sensitivity after sciatic nerve injury
in wild-type and MT5-MMP-de¢cient mice. A: In wild-type mice,
paw withdrawal thresholds (presented as 50% threshold) following
mechanical stimulation for the injured side (¢lled circles) showed a
signi¢cant decrease compared with the sham-operated side (open
circles). B: In MT5-MMP-de¢cient mice, no reduction in mechani-
cal sensitivity was observed throughout the 28-day study period. As-
terisks indicate P6 0.01 (Mann^Whitney U-test) ; n=9 for wild-type
and n=6 for MT5-MMP-de¢cient mice.
Fig. 3. A: Schematic diagram of the spinal cord at L4. B: Boxed
area of A. I^VI, cytoarchitectonic laminae; DRG, dorsal root gan-
glion; AL, myelinated AL-¢bers; C, unmyelinated C-¢bers. A ¢lled
square indicates the cell body of the nociceptive-speci¢c neuron. C:
After peripheral nerve injury, AL-¢bers sprout from laminae III^VI
into lamina II. Arrows indicate the injection site of CTB.
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4B) as in the previous studies [21,22,25]. In contrast, CTB-
HRP staining in lamina II was clearly absent on the injured
side of MT5-MMP-de¢cient mice (Fig. 4D). Thus, MT5-
MMP is important in the sprouting and invasion by AL-¢bers
into lamina II after sciatic nerve injury.
Neurons are reported to express multiple MMPs and have
been suggested to play roles in the remodeling of surrounding
ECM components [31,32]. However, their in vivo function in
the nervous system has remained to be elucidated. Thus, this
is the ¢rst demonstration that one of the MMPs expressed in
neurons plays a critical role in neuronal plasticity accompany-
ing the structural remodeling of the nervous system. However,
the critical substrates that have to be degraded by MT5-MMP
during the process remain to be studied. Previously, MT5-
MMP was reported to degrade the core proteins of chondroi-
tin sulfate proteoglycans (CSPGs) [33] that are abundant in
neuronal tissues [34]. Since CSPGs are inhibitory to neurite
outgrowth [35,36], they are possible targets of MT5-MMP in
the tissue.
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Fig. 4. CTB-HRP labeling in dorsal horn lamina II following sciatic
nerve transection. CTB-HRP is bilaterally injected into the sciatic
nerve 14 days after sciatic nerve transection and examined in the
dorsal horn in L4^L5 segments of spinal cord 17 days after axoto-
my. Sham-operated side in wild-type mice (A) and MT5-MMP-de¢-
cient mice (C). Note that lamina II (asterisks) in each genotype is
devoid of labeling. Injured side in wild-type mice (B) and MT5-
MMP-de¢cient mice (D). In wild-type mice, CTB-HRP label is
present in lamina II as well as the other laminae. In contrast, lami-
na II in MT5-MMP-de¢cient mice is completely devoid of labeling
as observed on the sham-operated side. Scale bar= 100 Wm.
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